Discover and read the best of Twitter Threads about #InternationalCancerCOVID19Vaccine
Most recents (1)
2nd paper 📰📰 Vaccine Cohort 💉 We analysed vaccine responses in 585 patients with cancer after COVID-19 vaccination, measuring neutralising responses against the original SARS-CoV-2 and variants of concern (incl. Delta) and T cell responses (1/11) 
After two doses of either Pfizer-BionTech or Oxford-AstraZeneca, 83% of infection-naïve patients with cancer developed antibodies against the original strain, but only 54% of those had neutralising antibodies against Delta (2/11)
Importantly, we show that while the proportion of patients with S1-reactive antibodies is concordant to patients with NAb against WT SARS-CoV-2 it can overestimate neutralising responses against variants of concern (3/11)
